Annovis Bio to Shed Light on Neurodegenerative Diseases at International Conference

Annovis Bio

MALVERN, PA — Chester County-based Annovis Bio, Inc. (NYSE: ANVS) is set to make a significant impact at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™ 2024) in Lisbon, Portugal this March. The conference will provide a global platform for the company’s innovative approach to treating neurodegenerative diseases.

The company’s Founder, President, and CEO, Maria Maccecchini, PhD, will participate in a forum discussion focused on new approaches for alpha-synuclein (αSyn), LRKK2, and GBA pathologies. All three are key players in the development of neurodegenerative diseases such as Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy.

Alpha-synuclein, in particular, has been identified as a main constituent of Lewy bodies, abnormal aggregates of protein that develop inside nerve cells, disrupting their function. The panel will discuss the use of biomarkers to differentiate Parkinson’s disease from other diseases characterized by the presence of αSyn, and to track the course and progression of these diseases.

The forum will feature a stellar line-up of international discussants, including experts from University San Raffaele Roma, Roche, CervoMed, Inc., Mayo Clinic, Medical University of Innsbruck, and Biogen. The session is set to take place on March 7, 2024, from 17:30 – 18:30 in Auditorium I.

Annovis Bio is a clinical-stage drug platform company uniquely positioned in the fight against neurodegeneration. It is believed to be the only company developing a drug designed to inhibit more than one neurotoxic protein, thereby aiming to restore axonal transport and synaptic activity. This approach could potentially improve brain function and treat memory loss and dementia associated with Alzheimer’s Disease, as well as body and brain dysfunction associated with Parkinson’s Disease.

READ:  Cancer Care at the Cutting-Edge: Insights from the NCCN 2024 Annual Conference

As Annovis Bio continues its groundbreaking work in the field of neurodegeneration, the insights shared at this international conference could potentially pave the way for significant advances in our understanding and treatment of these debilitating diseases.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and Microsoft Start.